Develops drugs for rare blood cancers.
Dec 2024Revenue $134M/yrExpenses $188M/yr
No trend
Figures by year
When will Ascentage Pharma Group International be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2024, revenue was $134M and expenses $188M.
| Fiscal year to | Revenue | Expenses | Pre-tax profit |
|---|---|---|---|
| Dec 2024 | $134M | $188M | −$54.1M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.